Clinical Research Directory
Browse clinical research sites, groups, and studies.
Evaluation of Circulating Tumor Cells (CTC) Relevance in Breast Cancer Follow-up Using the ScreenCell Device
Sponsor: ScreenCell
Summary
Liquid biopsy is a noninvasive method for detecting and quantifying circulating tumor cells (CTCs). Thanks to ScreenCell technology, this study aims to evaluate the evolution of the number of CTCs during breast cancer follow-up. The identification and characterization of CTCs would make it possible to obtain information on the stage and molecular characteristics of cancer during follow-up
Key Details
Gender
FEMALE
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
93
Start Date
2025-02-24
Completion Date
2026-11-30
Last Updated
2025-03-11
Healthy Volunteers
Yes
Conditions
Interventions
The DM/DIV ScreenCell is the experimental product studied during this research
The product is not used directly on the subject, but on a blood sample taken from the participant.
Locations (1)
CMC Ambroise Paré Hartmann
Neuilly-sur-Seine, France